| No. |
Sex |
Etiology |
AFP |
U% |
DCP |
HCC
/Non-HCC |
Imaging |
Size of
tumor
(cm) |
Number of
tumor |
| 1 |
M |
HBV |
8.4 |
74.2 |
0.89 |
HCC |
MRI |
3.5x2.4 |
1 |
| 2 |
F |
HBV |
2419.3 |
9.6 |
0.26 |
HCC |
MRI |
1.7x1.8 |
1 |
| 3 |
M |
HBV |
3.1 |
10.7 |
0.24 |
Suspious |
MRI |
0.7 |
1 |
| 4 |
M |
HBV |
206.1 |
2.5 |
79.88 |
HCC |
MRI |
1.2 |
1 |
| 5 |
M |
HBV |
2.3 |
0.5 |
0.38 |
HCC |
MRI |
1.6x1.4 |
1 |
| 6 |
M |
HBV |
9.3 |
28.8 |
0.37 |
HCC |
MR1 |
3.0, 4.0 |
2 |
| 7 |
M |
HBV |
3.8 |
0.5 |
0.10 |
HCC |
MRI |
2.0 |
1 |
| 8 |
M |
HBV |
4.3 |
7.0 |
0.11 |
Suspious |
MRI |
2.0x1.8 |
1 |
In 5 among 8 patients with specimens after successful treatment, the AFP-L3 values were elevated before the recurrence (by MRI) in comparison to only 2 each for AFP
and DCP (cut-offs for L3% 4.5 and for DCP 0.57). |
